BELLEVUE GROUP AG Krystal Biotech, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$1.27M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

+6.15%
quarter

Krystal Biotech, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +36.57% 4.9K shares 396K $69.7 18.3K
Q2 2022 share Decrease -2.90% -400 shares -38K $65.66 13.4K
Q1 2022 share Decrease -1.43% -200 shares -61K $66.54 13.8K
Q4 2021 share Increase 0.00% 14K shares 979K $70.5 14K